Navigation Links
Artificial discs available as replacements for damaged discs

Patients with damaged discs have traditionally been treated by removing a disc or placing a bone graft in the spine to fuse two bones together. Now, an artificial disc which is being studied as a replacement is in the second phase of trials. The phase one study that was recently completed compared the prosthesis to traditional fusion. While in the first phase of trials patients// were randomized, with one having a fusion operation for every two that received the artificial disc, in the second phase all patients who qualify to participate in the study will receive the artificial disc.

A healthy disc is a complex structure between the bones of the spine. The nucleus, sandwiched in the center of the disc, contains fluid that serves as a cushion. Layered collagen fibers of the adjacent annulus provide strength. When the components work together, they give the back both stability and flexibility. But when a disc is damaged, the cushion can deflate, bulge or leak, and the collagen loses its elasticity. Pain is often intense, especially when nerves get caught between degenerating components. While fusion may relieve the pain, it prevents natural, independent motion.

The artificial disc being studied would be inserted by surgeons through the the abdomen, just below the navel, sparing the large muscles of the back. Compared to traditional fusion surgery, inserting the disc takes lesser time at the operating table (about one and half years) and the patients are mobile right away contrary to those undergoing fusion surgery, who have their motion restricted for up to a year. The other major benefit that the artificial disc appears to offer is that motion remains at the disc, which does not put additional stress on adjacent discs.

In fusion surgery, in the long term, people often come back with problems at the next disc, and they may need another operation. The artificial disc may prove to be a viable alternative, especially for younger, active p atients. The Food & Drug Administration is yet to approve the device for general use throughout the United States as it waiting for the results of the second phase of the trials. The drug has already been approved in Europe.


'"/>




Related medicine news :

1. Fifth US Patient Receives Artificial Heart
2. First Artificial Heart patient has Major setback
3. Artificial lenses- Boon to cataract patients
4. Artificial silicon retina
5. Artificial disc looks hopeful
6. Artificially made protein to inhibit angiogenesis
7. Artificial Heart , Gives Hope For Patients Awaiting a Heart Transplant
8. Artificial Sweetners Not Really Safe?
9. Aspartame, Artificial Sweetener, A Safe Bet!
10. Artificial Light Stimulates Breast Cancer Growth In Mice: Study
11. Artificial sweetener, Aspartame, may be the potential cause of lymphoma, leukaemia
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/20/2017)... ... ... “The Trials I Face to Receive God’s Grace”: a mesmerizing take ... goals to better one’s life through God. “The Trials I Face to Receive God’s ... wrong places, found a love for writing. Green feels that expressing his feelings through ...
(Date:9/20/2017)... ... ... Houston, Texas, investment firm CORDA Investment Management, LLC, believes in giving back. ... work and rolled up their sleeves to help with relief efforts. The team picked ... process of rebuilding. , CORDA founder Bonner C. Barnes notes that investment management firms ...
(Date:9/20/2017)... ... September 20, 2017 , ... “The Foggy Road to Moorwick”: the adventures of a young ... creation of published author, Jeanine Liston, a busy mother of five who used her time ... been writing this book for over twenty years. It was a way to give ...
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “Monique”: ... into uncomfortable situations. “Monique” is the creation of published author, Colleen Crispi, has owned ... Since then Crispi has been involved in real estate and cooking. , “The ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, ... marketing leader, Denise Flannery, to its strategic advisory and client development team. ... will work with clients across different industries to develop and implement market-justified strategies, ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 9, 2017  Eli Lilly and Company (NYSE: ... endpoint data for lasmiditan, an investigational, oral, first-in-class molecule ... significant improvements compared to placebo in the Phase 3 ... the 18th Congress of the International Headache Society (IHC) ... data presented today demonstrate lasmiditan,s potential to reduce pain ...
(Date:9/7/2017)... Caris Life Sciences, a leading innovator ... of precision medicine, today announced results from two ... molecular profiling approach in guiding therapeutic strategies in ... (CGP+) with Caris Molecular Intelligence ® to ... level, leading to more therapeutic options and improved ...
(Date:9/7/2017)... , Sept. 7, 2017   BioLife Solutions , Inc. ... marketer of proprietary clinical grade cell and tissue hypothermic ... that Mike Rice , President and CEO, will be ... Rodman & Renshaw 19 th Annual Global ... time (12:25 p.m. Pacific time). The conference is being held ...
Breaking Medicine Technology: